Myriad Genetics Inc. (MYGN) Reports In-Line Q2 EPS; Guides FY11 EPS Shy
Tweet Send to a Friend
Myriad Genetics Inc. (NASDAQ: MYGN) reported Q2 EPS of $0.26, in-line with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
